Correcting for Brain Swelling’s Effects on Infarct Volume Calculation After Middle Cerebral Artery Occlusion in Rats

Translational Stroke Research

Volumn 6, Issue 4, 2015, Pages 323-338

  McBride, Devin W ^a   Klebe, Damon ^a   Tang, Jiping ^a   Zhang, John H ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain swelling; Infarct volume; Infarction; MCAO; Middle cerebral artery occlusion

Indexed keywords

TRIPHENYLTETRAZOLIUM; TETRAZOLIUM;

ADULT; ALGORITHM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN SIZE; BRAIN TISSUE; CONTROLLED STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN; CEREBRAL ARTERY DISEASE; COMPLICATION; DISEASE MODEL; HEMISPHERIC DOMINANCE; IMAGE PROCESSING; METABOLISM; PATHOLOGY; REPERFUSION; SPRAGUE DAWLEY RAT; TIME FACTOR;

ALGORITHMS; ANIMALS; BRAIN; BRAIN EDEMA; DISEASE MODELS, ANIMAL; FUNCTIONAL LATERALITY; IMAGE PROCESSING, COMPUTER-ASSISTED; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION; TETRAZOLIUM SALTS; TIME FACTORS;

EID: 84933678183     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-015-0400-3     Document Type: Article

References (49)

1. Dirnagl U, Fisher M. International, multicenter randomized preclinical trials in translational stroke research: it’s time to act. J Cereb Blood Flow Metab. 2012;32(6):933–5.
2. Schabitz WR, Fisher M. Perspectives on neuroprotective stroke therapy. Biochem Soc Trans. 2006;34(6):1271–6.
3. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17(6):1304–8.
4. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17(3):472–6.
5. Carano RA, Li F, Irie K, Helmer KG, Silva MD, Fisher M, et al. Multispectral analysis of the temporal evolution of cerebral ischemia in the rat brain. J Magn Reson Imaging. 2000;12(6):842–58.
6. Duverger D, MacKenzie ET. The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. J Cereb Blood Flow Metab. 1988;8(4):449–61.
7. Hoff JT, Nishimura M, Newfield P. Pentobarbital protection from cerebral infarction without suppression of edema. Stroke. 1982;13(5):623–8.
8. Jiang Q, Chopp M, Zhang ZG, Knight RA, Jacobs M, Windham JP, et al. The temporal evolution of MRI tissue signatures after transient middle cerebral artery occlusion in rat. J Neurol Sci. 1997;145(1):15–23.
9. Jones PG, Coyle P. Microcomputer assisted lesion size measurements in spontaneously hypertensive stroke-prone rats. J Electrophysiol Tech. 1984;11:71–8.
10. Lundy EF, Solik BS, Frank RS, Lacy PS, Combs DJ, Zelenock GB, et al. Morphometric evaluation of brain infarcts in rats and gerbils. J Pharmacol Methods. 1986;16(3):201–14.
11. Nemoto E, Mendez O, Kerr M, Firlik A, Stevenson K, Jovin T, et al. CT density changes with rapid onset acute, severe, focal cerebral ischemia in monkeys. Translat Stroke Res. 2012;3(3):369–74.
12. Lin TN, He YY, Wu G, Khan M, Hsu CY. Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke. 1993;24(1):117–21.
13. Khanna A, Kahle KT, Walcott BP, Gerzanich V, Simard JM. Disruption of ion homeostasis in the neurogliovascular unit underlies the pathogenesis of ischemic cerebral edema. Translat Stroke Res. 2014;5(1):3–16.
14. Seifert HA, Pennypacker KR. Molecular and cellular immune responses to ischemic brain injury. Translat Stroke Res. 2014;5(5):543–53.
15. Song M, Yu SP. Ionic regulation of cell volume changes and cell death after ischemic stroke. Translat Stroke Res. 2014;5(1):17–27.
16. Swanson RA, Sharp FR. Infarct measurement methodology. J Cereb Blood Flow Metab. 1994;14(4):697–8.
17. Kawamura S, Yasui N, Shirasawa M, Fukasawa H. Rat middle cerebral artery occlusion using an intraluminal thread technique. Acta Neurochir. 1991;109(3–4):126–32.
18. Gartshore G, Patterson J, Macrae IM. Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia. Exp Neurol. 1997;147(2):353–60.
19. Kondo T, Reaume AG, Huang TT, Carlson E, Murakami K, Chen SF, et al. Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. J Neurosci. 1997;17(11):4180–9.
20. Osborne KA, Shigeno T, Balarsky AM, Ford I, McCulloch J, Teasdale GM, et al. Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia. J Neurol Neurosurg Psychiatry. 1987;50(4):402–10.
21. Geng X, Elmadhoun O, Peng C, Ji X, Hafeez A, Liu Z, et al. Ethanol and normobaric oxygen: novel approach in modulating pyruvate dehydrogenase complex after severe transient and permanent ischemic stroke. Stroke. 2015;46(2):492–9.
22. Liang X, Hu Q, Li B, McBride D, Bian H, Spagnoli P, et al. Follistatin-like 1 attenuates apoptosis via disco-interacting protein 2 homolog A/Akt pathway after middle cerebral artery occlusion in rats. Stroke. 2014;45(10):3048–54.
23. Liu X, Zhao S, Liu F, Kang J, Xiao A, Li F, et al. Remote ischemic postconditioning alleviates cerebral ischemic injury by attenuating endoplasmic reticulum stress-mediated apoptosis. Translat Stroke Res. 2014;5(6):692–700.
24. Su J, Zhang T, Wang K, Zhu T, Li X. Autophagy activation contributes to the neuroprotection of remote ischemic perconditioning against focal cerebral ischemia in rats. Neurochem Res. 2014;39(11):2068–77.
25. Harvey J, Rasmussen T. Occlusion of the middle cerebral artery: an experimental study. Arch Neurol Psychiatry. 1951;66(1):20–9.
26. Meyer JS, Denny-Brown D. The cerebral collateral circulation. I. Factors influencing collateral blood flow. Neurology. 1957;7(7):447–58.
27. Sundt Jr TM, Waltz AG. Experimental cerebral infarction: retro-orbital, extradural approach for occluding the middle cerebral artery. Mayo Clin Proc. 1966;41(3):159–68.
28. Robinson RG, Shoemaker WJ, Schlumpf M, Valk T, Bloom FE. Effect of experimental cerebral infarction in rat brain on catecholamines and behaviour. Nature. 1975;255(5506):332–4.
29. Chen ST, Hsu CY, Hogan EL, Maricq H, Balentine JD. A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. Stroke. 1986;17(4):738–43.
30. Chen ST, Hsu CY, Hogan EL, Juan HY, Banik NL, Balentine JD. Brain calcium content in ischemic infarction. Neurology. 1987;37(7):1227–9.
31. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 1990;10(2):290–3.
32. Belayev L, Khoutorova L, Deisher TA, Belayev A, Busto R, Zhang Y, et al. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats. Stroke. 2003;34(3):758–63.
33. Lee J, Lee JK, Han K. InfarctSizer: computing infarct volume from brain images of a stroke animal model. Comput Methods Biomech Biomed Eng. 2011;14(6):497–504.
34. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999;30(12):2752–8.
35. Tureyen K, Vemuganti R, Sailor KA, Dempsey RJ. Infarct volume quantification in mouse focal cerebral ischemia: a comparison of triphenyltetrazolium chloride and cresyl violet staining techniques. J Neurosci Methods. 2004;139(2):203–7.
36. Boltze J, Nitzsche B, Geiger KD, Schoon H-A. Histopathological investigation of different MCAO modalities and impact of autologous bone marrow mononuclear cell administration in an ovine stroke model. Translat Stroke Res. 2011;2(3):279–93.
37. Leach MJ, Swan JH, Eisenthal D, Dopson M, Nobbs M. BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage. Stroke. 1993;24(7):1063–7.
38. Liu X, Ye M, An C, Pan L, Ji L. The effect of cationic albumin-conjugated PEGylated tanshinone IIA nanoparticles on neuronal signal pathways and neuroprotection in cerebral ischemia. Biomaterials. 2013;34(28):6893–905.
39. Ostrowski RP, Schulte RW, Nie Y, Ling T, Lee T, Manaenko A, et al. Acute splenic irradiation reduces brain injury in the rat focal ischemic stroke model. Translat Stroke Res. 2012;3(4):473–81.
40. Anderson DC, Bottini AG, Jagiella WM, Westphal B, Ford S, Rockswold GL, et al. A pilot study of hyperbaric oxygen in the treatment of human stroke. Stroke. 1991;22(9):1137–42.
41. England TJ, Gibson CL, Bath PM. Granulocyte-colony stimulating factor in experimental stroke and its effects on infarct size and functional outcome: a systematic review. Brain Res Rev. 2009;62(1):71–82.
42. Singhal AB, Benner T, Roccatagliata L, Koroshetz WJ, Schaefer PW, Lo EH, et al. A pilot study of normobaric oxygen therapy in acute ischemic stroke. Stroke. 2005;36(4):797–802.
43. Jin G, Sun PZ, Singhal AB, Ayata C, Lo EH. First-order mathematical modeling of brain swelling in focal cerebral ischemia. Translat Stroke Res. 2010;1(1):65–70.
44. Mitkari B, Kerkela E, Nystedt J, Korhonen M, Jolkkonen J. Unexpected complication in a rat stroke model: exacerbation of secondary pathology in the thalamus by subacute intraarterial administration of human bone marrow-derived mesenchymal stem cells. J Cereb Blood Flow Metab. 2015;35(3):363–6.
45. Bhattacharya P, Pandey AK, Paul S, Patnaik R, Yavagal DR. Aquaporin-4 inhibition mediates piroxicam-induced neuroprotection against cerebral ischemia/reperfusion injury in rodents. PLoS ONE. 2013;8, e73481.
46. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke. 2009;40(6):2244–50.
47. Lapchak PA, Zhang JH, Noble-Haeusslein LJ. RIGOR guidelines: escalating STAIR and STEPS for effective translational research. Translat Stroke Res. 2013;4(3):279–85.
48. Fisher M, Tatlisumak T. Use of animal models has not contributed to development of acute stroke therapies: con. Stroke. 2005;36(10):2324–5.
49. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1(8476):307–10.